Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Quick Answer: GLP-1 medications can increase bowel frequency and cause looser stools in some patients, though individual responses vary considerably
My energy is through the roof, and my skin and hair have never looked better! David R
CONNECT WITH TARA TikTok and Instagram: @tacklingtara Links and resources: SPONSOR Tyde Wellness GLP-1 programs with licensed providers, real dosing adjustments, and long-term support code GLP1Hub50 for $50 off your first month CHAPTERS 00:00 From clinical trial to a 222-pound weight loss 01:11 Meet Tara Rothenhoefer 03:16 A lifelong battle with obesity and dieting 04:48 Finding the tirzepatide clinical trial 08:15 Taking a chance on an unknown medication 10:58 What the trial support looked like 13:56 Movement, nutrition support, and early results 16:54 Losing 132 pounds in 18 months 20:00 When the trial ended and medication access disappeared 29:00 Shortages, stigma, and public attention 35:11 When weight loss went too far 40:24 Long-term maintenance and listening to her body 43:03 Connecting with Tara MORE FROM GLP-1 HUB Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show
The inability to sustain weight loss may be due to PYY 3-36 -induced Y2-R down-regulation and tolerance (i.e., tachyphylaxis) and/or activation of compensatory mechanisms in response to reduced food intake
This is fundamentally different from tirzepatide, which is available by prescription as Mounjaro and Zepbound
